| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
138,800,000 |
| Market
Cap: |
1.46(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$4.7 - $15 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Maravai is a holding company. Through its subsidiaries, Co. operates as a life sciences company that provides products to enable the development of drug, therapies, diagnostics, vaccines, and support research on human diseases. Co. operates in two segments: Nucleic Acid Production, which includes messenger ribonucleic acid, long and short oligonucleotides, its CleanCap® capping technology and oligonucleotide building blocks; and Biologics Safety Testing, which sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lucier Gregory T |
Director |
– • – |
2023-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
55,123 |
|
- |
|
| Prahalad Murali |
Director |
– • – |
2023-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
44,823 |
|
- |
|
| Leddy Peter Michael |
See Remarks |
• – – |
2023-07-17 |
4 |
D |
$12.52 |
$69,837 |
D/D |
(5,578) |
132,347 |
|
- |
|
| Ashkenazi Anat |
Director |
– • – |
2023-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
40,123 |
|
- |
|
| Cunningham Sean Laurence |
Director |
– • – |
2023-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
28,271 |
|
- |
|
| Mihas Constantine S |
Director |
– • – |
2023-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
28,271 |
|
- |
|
| Daverman Benjamin James |
Director |
– • – |
2023-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
28,271 |
|
- |
|
| Gray Susannah |
Director |
– • – |
2023-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
60,123 |
|
- |
|
| Marker Luke Joseph |
Director |
– • – |
2023-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
28,271 |
|
- |
|
| Hopfield Jessica |
Director |
– • – |
2023-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
90,123 |
|
- |
|
| Herde Kevin |
Chief Financial Officer |
• – – |
2023-04-28 |
4 |
A |
$11.72 |
$10,243 |
D/D |
874 |
92,064 |
|
- |
|
| Leddy Peter Michael |
See Remarks |
• – – |
2023-04-28 |
4 |
A |
$11.72 |
$22,502 |
D/D |
1,920 |
137,925 |
|
- |
|
| Dolan Christine |
See Remarks |
• – – |
2023-04-28 |
4 |
A |
$11.72 |
$16,338 |
D/D |
1,394 |
73,998 |
|
- |
|
| Oreshack Kurt |
General Counsel |
• – – |
2023-04-28 |
4 |
A |
$11.72 |
$11,884 |
D/D |
1,014 |
63,370 |
|
- |
|
| Buzzeo Rebecca |
See RemarksOfficer |
• – – |
2023-03-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
85,783 |
|
-26% |
|
| Oreshack Kurt |
General Counsel |
• – – |
2023-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
38,386 |
62,356 |
|
- |
|
| Dolan Christine |
See Remarks |
• – – |
2023-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
55,775 |
72,604 |
|
- |
|
| Leddy Peter Michael |
See Remarks |
• – – |
2023-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
72,507 |
136,005 |
|
- |
|
| Herde Kevin |
Chief Financial Officer |
• – – |
2023-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
72,507 |
91,190 |
|
- |
|
| Hull Carl |
Chief Executive Officer |
• • – |
2023-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
147,638 |
219,519 |
|
- |
|
| Neel Brian |
See Remarks |
• – – |
2023-02-15 |
4 |
D |
$15.23 |
$35,212 |
D/D |
(2,312) |
16,473 |
|
- |
|
| Oreshack Kurt |
General Counsel |
• – – |
2023-02-15 |
4 |
D |
$15.23 |
$35,212 |
D/D |
(2,312) |
23,970 |
|
- |
|
| Hull Carl |
Chief Executive Officer |
• • – |
2023-02-15 |
4 |
D |
$15.23 |
$148,020 |
D/D |
(9,719) |
71,881 |
|
- |
|
| Dolan Christine |
See Remarks |
• – – |
2023-02-15 |
4 |
D |
$15.23 |
$29,790 |
D/D |
(1,956) |
16,829 |
|
- |
|
| Herde Kevin |
Chief Financial Officer |
• – – |
2023-02-15 |
4 |
D |
$15.23 |
$39,766 |
D/D |
(2,611) |
18,683 |
|
- |
|
102 Records found
|
|
Page 2 of 5 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.07 (0.67%) 
